I'd love you to stick around for an update of that list.
Till then, I have a nightmare list for you instead, all that you lot continously hoped for and said would not happen.
1) Reached data lock. 2) Top line data announced. 3) Results peer reviewed and published in JAMA 4) Commercially approved to manufacture DCVax-L 5) PIP plan approved by MHRA including using original trial design 6) DCVax-L in two combo trials at UCLA showing extreme efficacy 7) Nature to publish current results of DCVax-L / Poly-iclc trial 8) Linda Liau joins NWBO SAB board 9) British politicians urges MHRA to approve and NICE to reimburse DCVax-L in "Pathway to a Cure" report 10) NWBO to submit for MAA approval with MHRA during coming month